Skip to content

OnKure Therapeutics, Inc.

OKUR· NasdaqCore metricsCIK 1637715

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -10.16%
Market cap
$121.71M
40.5M shares
Filings
405
$0.00
FY 2024
—
-$17.85M
Q3 2026N/M FY25 yoy
-$19.35M
Q3 2026N/M FY25 yoy
-$36.41M
Q3 2026derivedN/M FY25 yoy
-$0.36
Q3 2026N/M FY25 yoy
$151.44M
Q3 2026−46.7% FY25 yoy
$121.71M
—
—
0.8×
-42.62%
—

FY2025 figures · derived

Price

$3.014.91%$0.16past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2024
$0.000FY 2024
PeriodEndedValueKindSource trail
FY 20242024-12-31$0reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2023—$4.40M$4.40M—33.42M sh+33.1%—

Pharmaceutical preparations

OnKure Therapeutics, Inc. is the 279th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

OnKure Therapeutics, Inc. · CIK 1637715 · Engraved from SEC EDGAR